This announcement is a separate document:
天大藥業：持續關聯交易超出2022年度上限
TIANDA PHARMA: CONTINUING CONNECTED TRANSACTIONS 2022 ANNUAL CAP EXCEEDED
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.